| |
|
|
|
Matinas BioPharma Holdings Inc.  
|
|
1 -0.03 (-0.03%) |
04-18 12:53 |
|
Open: |
1.03 |
Pre close: |
1.03 |
Target:
|
1.39 
|
|
High: |
1.0377 |
Low: |
0.94 |
Resistance:
|
1.19
1.35
|
|
Volume: |
1,244,494 |
Market Cap: |
143M |
Support:
|
0.94
0.78
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.04
|
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
1.08 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
0.98  |
Stochastic Oscillator |
%K(14,3):
|
18.91 |
|
MA(250): |
0.74 |
%D(3): |
20.82 |
|
Average Volume(K) |
3-Month: |
104142
|
52-Week |
High:
|
1.50 |
|
10-Days: |
74275 |
Low: |
0.32 |
|
RSI |
RSI(14):
|
37.70 |
Change(%): |
45.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-269.7 |
Shares Out. (M) |
142.94 |
|
EPS Est. Current Year |
-0.290 |
Return on Assets (ttm) |
-88.8 |
Shares Float (M) |
133.58 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
-100.0 |
% Held by Institutions |
16.50 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
4940 |
|
Book Value (p.s.) |
24.490 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.04 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.32 |
P/S |
0.00 |
|
Operating Margin |
-12230.93 |
Levered Free Cash Flow
(M) |
-4.64 |
P/CF |
-13.71 |
|
|
|
|
|
|
